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1. Introduction 
Mutations in Cu/Zn superoxide dismutase (SOD1) gene are linked to the motor neuron 
death in familial amyotrophic lateral sclerosis (FALS). More than 100 missense mutations 
have been described to cause the disease and are distributed throughout the whole 153 
amino acid sequence of SOD1 molecule (Valentine et al., 2005; Boillée et al., 2006). Mutant 
SOD1 molecules can be grouped according to their biochemical characteristics into wild 
type-like proteins, that bind metal ions and possess enzymatic dismutase activity (e.g. 
G93A-SOD1 and G37R-SOD1), and mutant molecules with impaired metal binding capacity, 
which have significantly reduced dismutase activity (e.g. G85R-SOD1) (Valentine et al., 
2005). Therefore, the toxicity of mutant SOD1 is not thought to be mediated by a lack of 
dismutase activity, but rather by gain of one or more detrimental functions.  
The exact nature of the toxic gain of function for mutant SOD1 has not been identified yet. 
Most of the studies demonstrate a link between the disease pathology and increased 
oxidative stress. Augmented generation of free radicals and reactive oxygen species (ROS) is 
thought to be a major contributor to the destruction of motor neurons (Beckman et al., 1994; 
Wiedau-Pazos et al., 1996; Estévez et al., 1999).  
The suggested toxic mechanisms include aberrant mutant SOD1 enzymatic activities 
(Beckman et al., 1993; Wiedau-Pazos et al., 1996) as well as destabilized SOD1 protein 
misfolding, causing enhanced aggregation of SOD1 or pathological interaction of SOD1 with 
other proteins (Stathopulos et al., 2003; Liu et al., 2004).  
In a number of studies mitochondrial localization of mutant SOD1 has been implicated in 
ALS pathogenesis (Liu et al., 2004; Vijayvergiya et al., 2005; Bergemalm et al., 2006; Deng et 
al., 2006; Ferri et al., 2006) and increased recruitment of mutant SOD1 into mitochondria in 
the spinal cord might be a reason for death of motor neurons in some forms of familial ALS. 
However, the detailed mechanisms for toxicity of the mitochondria resident mutant SOD1 
are not entirely clear yet. Here we review the current state of the art in the studies on 
mitochondrial toxicity of SOD1 in ALS.  
2. Factors controlling SOD1 translocation to mitochondria and SOD1 activity 
in mitochondrial intermembrane space 
Although the majority of SOD1 is present in the cytosol (Okado-Matsumoto & Fridovich, 
2001), a fraction of SOD1 is translocated into the mitochondrial intermembrane space (IMS) 
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(Sturtz et al., 2001; Higgins et al., 2002). Since SOD1 does not contain mitochondrial 
targeting sequence, the true physiological function of SOD1 in the IMS remains mostly 
enigmatic.  
In mammalian cells the mitochondrial localization of SOD1 is regulated by the folding state 
of this enzyme, depending on the intracellular distribution of copper chaperone for SOD1 
(CCS), which in turn is regulated by oxygen concentration. Redox status of the cysteine 
residues in human SOD1 is critical for its retention in mitochondria. The cysteine residues 
form intramolecular disulphide bonds and interact with CCS (Kawamata & Manfredi, 2008). 
This regulation appears to be impaired for SOD1 mutants, which can lead to misfolding and 
aggregation of mutant SOD1 and eventually result in SOD1 accumulation inside the 
mitochondria. In animal models the mitochondrial association of mutant SOD1 is apparent 
even before the disease onset (Liu et al., 2004), indicating a causative link of mitochondrial 
SOD1 to the initiation of pathology. 
Even though SOD1 has been suggested to be an important part of the mitochondrial 
superoxide scavenging system, as previously demonstrated in the yeast (Sturtz et al., 2001) 
and rat (Iñarrea et al., 2005) mitochondrion IMS, SOD1 activity is kept under redox control 
in this compartment and undergoes activation upon increased hydroperoxide concentration 
(Iñarrea et al., 2005).  
There are 4 cysteines in the human SOD1 molecule, located at 6, 57, 111 and 144 position of 
the sequence. The intramolecular disulphide bridge between Cys57 and Cys146 is required 
for the proper tertiary and quaternary structure and enzymatic activity of SOD1 (Arnesano 
et al., 2004). Diminished copper loading and reduced intramolecular disulphide bound has 
been thought to be responsible for increased aggregation potential of G93A and D90A 
mutant SOD1 (Jonsson et al., 2006). 
The maturation and activation of SOD1 in the cytosol is controlled by a number of factors 
and can be divided in several principal steps. Upon post-translational activation, an SOD1 
monomer binds a Zn2+ ion. Next ,CCS transiently binds to SOD1 monomer and inserts a 
Cu2+ ion in the molecule (Culotta et al., 1997; Casareno et al., 1998). After the dissociation of 
SOD1 from CCS, oxidative formation of disulphide bounds takes place (Arnesano et al., 
2004; Ding & Dokholyan, 2008), which is followed by dimerisation yielding an active SOD1 
molecule (Vonk et al., 2010).  
Active SOD1 dimers are not capable of entering mitochondria, in contrast to disulphide 
reduced apo-SOD1. According to the model proposed (Kawamata & Manfredi, 2008; 
Reddehase et al., 2009), CCS is first imported into mitochondria by interaction with Mia40, 
an IMS component critical for protein import to mitochondria. The CCS-Mia40 complex is 
formed through an intermolecular disulphide bound (Fig. 1.). Further disulphide 
rearrangement generates oxidized CCS, preventing its escape from the IMS. The activation 
of SOD1 in IMS is thought to be similar to the activation of SOD1 in cytosol, where SOD1 
binds to CCS in the presence of Cu2+ ions and oxygen generating an active enzyme retained 
in IMS (Leitch et al., 2009).  
Surprisingly, CCS overexpression in G93A-SOD1 mouse, a widely used transgenic mouse 
model of ALS, produces severe mitochondrial pathology and accelerates disease course (Son 
et al., 2007). According to the model above, the potentiation of mutant SOD1 toxicity by CCS 
overexpression can be explained by the CCS-mediated increase in SOD1 mitochondrial 
import, leading to enhanced SOD1 aggregation. 
In contrast to the model of CCS-dependent activation of mitochondrial SOD1, a number of 
recent studies suggest that SOD1 in the IMS of intact mitochondria is mostly inactive and an 
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oxidative modification of its critical thiol groups is necessary for the activation (Iñarrea et 
al., 2005, 2011; Goldsteins et al., 2008). This activation, at least partly, depends on protein 
disulphide isomerase (PDI) activity (Iñarrea et al., 2005). On the other hand, the toxicity of 
mutant SOD1 is not correlated with its aggregation potential but with the ability to form 
active dimeric molecules (Witan et al., 2008). These findings are in concert with a concept 
that mitochondrial dysfunction and cell damage are paradoxically induced by SOD1-
mediated hydroperoxide production in the IMS (Goldsteins et al., 2008). 
 
 
Fig. 1. Import and activation of SOD1 in IMS. CCS is imported into mitochondria through 
formation of a complex with Mia40 (I). Disulphide-reduced SOD1 monomer enters IMS and 
acquires copper ion (Cu2+) with a help of CCS (II). Formation of intramolecular disulphide 
bound and dimerisation of SOD1 creates an active SOD1 molecule retained in IMS (III). 
3. Proposed mechanisms for mutant SOD1 toxicity in mitochondria 
Mitochondrial abnormalities and degeneration of motor neurons are early signs of ALS 
disease (Wong et al., 1995; Dal Canto & Gurney, 1997; Kong & Xu, 1998). They also represent 
pathological hallmarks in mutant SOD1 transgenic animal models for FALS as well as in 
patients with sporadic ALS (Kong & Xu, 1998; Mattiazzi et al., 2002; Manfredi & Xu, 2005). 
Mitochondrial toxicity may thus be an important factor in the degeneration of motor 
neurons. The pathology, demonstrated in sporadic ALS cases includes mitochondrial 
aggregates, mitochondrion swelling and increased calcium levels in mitochondria (Atsumi, 
1981; Siklós et al., 1996). In G93A-SOD1 transgenic mice the disease onset is associated with 
a remarkable increase of vacuolated mitochondria in motor neurons (Kong & Xu, 1998). It 
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has been proposed that formation of vacuoles originates from the expansion of 
mitochondrial IMS and degeneration of mitochondrial matrix (Jaarsma et al., 2001; Bendotti 
et al., 2001; Higgins et al., 2003; Xu et al., 2004). 
Currently, there is no consensus on how mutant SOD1 causes mitochondrial pathology. The 
proposed mechanisms for mitochondrial toxicity of mutant SOD1 are summarized in Table 
1. Among other toxic mechanisms reduced activities of respiratory complexes (Browne et al., 
1998), mitochondrial depolarization and impaired calcium homeostasis (Kruman et al., 1999) 
have been demonstrated in the spinal cord of G93A-SOD1 mice. The observed dysfunctions 
of mitochondria might be caused by the recruitment of mutant SOD1, which has been 
shown to be selective to spinal cord mitochondria (Stathopulos et al., 2003; Liu et al., 2004; 
Pasinelli et al., 2004).  
 
TOXIC MECHANISM REFERENCES 
Aggregate accumulation in mitochondria 
(Higgins et al., 2002; Vande Velde et 
al., 2008) 
Aberrant mutant SOD1 enzymatic activities, 
causing ROS production 
(Estévez et al., 1999; Elliott, 2001) 
Impaired energy metabolism 
(Siciliano et al., 2001; Mattiazzi et 
al., 2002) 
Impaired Ca2+ buffering  
(Jaiswal & Keller, 2009; Grosskreutz 
et al., 2010) 
Gain in pro-apoptotic function (Pasinelli et al., 2004) 
Interfering with mitochondrial protein import (Liu et al., 2004) 
Increased hydroperoxide production in IMS (Goldsteins et al., 2008) 
Table 1. Proposed mechanisms for mitochondrial toxicity of mutant SOD1 
Among the proposed mechanisms, impairment of mitochondrial calcium buffering capacity 
has been shown in motor neurons of transgenic ALS mice (Damiano et al., 2006). On the 
other hand, ATP levels have been reported to be diminished in spinal cords of mutant SOD1 
mouse model (Mattiazzi et al., 2002). Another view to the mitochondrial toxicity of mutant 
SOD1 was brought up by Vande Velde et al., who demonstrated that misfolded mutant 
SOD1 damages mitochondria by its deposition onto the cytoplasmic side of the outer 
membrane of spinal cord mitochondria (Vande Velde et al., 2008).  
Other studies have demonstrated that the increased dismutase activity in rodent ALS 
models expressing mutant SOD1 paradoxically boosts the production of toxic ROS in the 
IMS (Goldsteins et al., 2008). It was shown that in a G93A-SOD1 rat model of ALS, the 
stability and quaternary structure of mutant SOD1 are lost most prominently in the spinal 
cord already several weeks before the onset of the disease (Ahtoniemi et al., 2008). These 
results suggest that destabilization of mutant SOD1 is associated with its increased binding 
to the inner mitochondrial membrane and elevated ROS production in the IMS. (Liu et al., 
2004; Kirkinezos et al., 2005; Ahtoniemi et al., 2008). 
Importantly, it was also recently demonstrated, that disulphide-reduced apo-SOD1 can 
rapidly initiate SOD1 fibrillation upon physiological conditions, suggesting that such 
disulphide-reduced apo-SOD1 may act as a seed for the amyloid like aggregates originating 
from the destabilized and folding intermediates of mutant SOD1 (Chattopadhyay et al., 
2008). 
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Despite of rather different mechanisms proposed for the toxic properties of mutant SOD1 in 
mitochondria, most of the recent studies document that mitochondrial dysfunction results in 
increased ROS production (Beretta et al., 2003). Mitochondria isolated from the neural tissue 
(brain, spinal cord) have distinct metabolic properties regarding the extent of ROS produced 
upon oxidation of respiratory substrates (Panov et al., 2011). Especially in G93A-SOD1 
transgenic rats, brain and spinal cord mitochondria generate 5–7 fold more ROS than 
mitochondria of corresponding wild-type tissues. Particularly, the spinal cord mitochondria 
produce two times more hydroperoxide than brain mitochondria of the same animals 
(Panov et al., n.d.)  
Analysis of mitochondrial morphology in G37R and G85R-SOD1 transgenic mice has 
revealed that somal mitochondria become shorter and rounder in both dismutase active 
and inactive mutant SOD1 mouse lines. In contrast, axonal mitochondria in G37R-SOD1 
animals shift from elongated tubular mitochondria to punctate mitochondria, while in 
G85R-SOD1 mice the mitochondria have been reported to show an increase in length 
(Vande Velde et al., 2011). These changes in mitochondrial shape and distribution were 
characteristic prior to ALS disease onset and support the notion of early mitochondrial 
pathology in ALS. 
4. SOD1 catalyzes increased hydroperoxide production in IMS 
The growing body of evidence provides support to the concept that superoxide dismutation 
in IMS may cause an increased hydroperoxide production with toxic consequences. 
Mitochondria are the major intracellular source of superoxide, the primary ROS, where 
superoxide anion radical is generated by one electron reduction of oxygen.  
The two major pathways of superoxide production in mitochondria are autooxidation or 
complex III catalyzed oxidation of ubisemiquinone (Muller et al., 2004) and complex I 
catalyzed reduction of oxygen through reversed electron flow in the respiratory chain (Fig. 
2.) (Liu et al., 2002). The produced superoxide anion radical has ability to actively react with 
a number of cellular targets leading to the loss of their proper function. The main 
detoxifying mechanism for superoxide instead of reverse oxidation of superoxide to oxygen, 
includes dismutation to hydroperoxide and oxygen.  
Besides SOD1, there are other dedicated enzymes catalyzing this dismutation reaction. In 
mitochondria Mn-superoxide dismutase (SOD2), which is found in the mitochondrial 
matrix, scavenges superoxide in this compartment. Extracellular superoxide dismutase 
(SOD3) is secreted into the extracellular space and protects tissues against excess of 
superoxide (Zelko et al., 2002). In the IMS superoxide is produced presumably by complex 
III (Fig. 2.) (Muller et al., 2004). Unlike hydroperoxide, which freely diffuses through the 
membranes, superoxide cannot cross the mitochondrial inner membrane. In the matrix 
SOD2 converts superoxide to hydroperoxide, which in turn is reduced to water by the 
matrix glutathione peroxidase (Inoue et al., 2003). Homozygous SOD2 knockout mice are 
neonatally lethal (Li et al., 1995), whereas deletion of SOD1 gene does not have apparent 
motor neuron disease phenotype (Maier & Chan, 2002). 
 In IMS the fate of superoxide is determined by SOD1 and cytochrome c, which is present 
there in millimolar concentrations (Forman & Azzi, 1997; van Beek-Harmsen & van der 
Laarse, 2005). Cytochrome c is a heme containing protein, which functions as an electron 
carrier between complex III and cytochrome oxidase in the respiratory chain. Cytocrome c 
can also efficiently oxidize superoxide to oxygen. In this respect, cytochrome c can function 
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as an efficient antioxidant, scavenging superoxide without production of secondary ROS 
(Fig. 2. reaction II), in contrast to SOD1, which produces hydroperoxide (Fig. 2, reaction III) 
(Pereverzev et al., 2003). However, cytochrome c has also a potential to catalyze oxidation 
by hydroperoxide. Upon this reaction, hydroperoxide oxidizes the prosthetic heme in the 
cytochrome c molecule to oxoferryl heme, forming so-called peroxidase compound I-type 
intermediate, a highly reactive oxidant that is able to react with a number of intracellular 
targets including proteins, nucleic acids and lipids, causing cell damage (Fig. 3) (Lawrence 
et al., 2003). Cytochrome c peroxidase activity is controlled by the coordination state of 
heme iron, particularly by the sulphur ligand of methionine-80 (Met-80), which can be easily 
displaced by hydroperoxide (Barr et al., 1996; Qian et al., 2002). The peroxidase activity of 
cytochrome c may increase by unfolding and post-translational modifications, such as 
proteolytic cleavage, nitration and oxidation (Diederix et al., 2002; Everse & Coates, 2005; 
Jang & Han, 2006).  
 
 
 
 
 
 
Fig. 2. Mitochondrial production and clearance of superoxide. Upon respiration superoxide 
is inevitably generated predominantly at respiratory complexes CI and CIII. The superoxide 
released to the matrix is dismutated by mitochondrial SOD2 (I) and the hydroperoxide 
produced is cleared by glutathione peroxidase and peroxyredoxins. Most of the superoxide 
released in IMS is generated at respiratory complex CIII. Oxidized form of cytochrome c, 
present in the IMS at high concentration can exercise clean clearance of superoxide by its 
oxidation to oxygen (II). An alternative dismutation catalyzed by SOD1 results in increased 
hydroperoxide generation in the IMS (III). 
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Fig. 3. Deleterious role of superoxide dismutase in the mitochondrial intermembrane space. 
Superoxide (O2.-) is released in IMS by one electron reduction of oxygen at a site in the inner 
membrane (I). Cu/Zn Superoxide dismutase (SOD1) in IMS is activated by oxidation of 
cysteine thiols, leading to formation of intramolecular S=S bounds (II). SOD1 produces 
hydroperoxide (H2O2) by dismutating superoxide (III). Hydroperoxide oxydizes cytochrome 
c (CytC) to oxoferryl-CytC (CytC(Fe4+=O)), an exceptionally strong oxidant (IV), able to 
oxidize a number of vital biological targets (V). 
We have recently proposed a model, where upon mitochondrial stress SOD1 may compete 
with cytochrome c for superoxide in the IMS and generate hydroperoxide, which then could 
react with cytochrome c and form peroxidase compound I-type intermediate, eventually 
leading to a deleterious increase in ROS production and cellular injury (Fig. 2) (Goldsteins et 
al., 2008). According to this model the SOD1-catalyzed superoxide dismutation in the IMS 
causes paradoxically augmented ROS production.  
The data obtained demonstrate that inhibition of electron transfer at the level of complex III 
leads to SOD1 activation in the IMS, resulting in increased hydroperoxide production and, 
consequently, cytochrome c-catalyze peroxidation (Goldsteins et al., 2008). This could 
trigger a vicious circle where oxidative damage to mitochondrial respiratory components 
leads to further ROS production and peroxidation. Indeed, we have demonstrated that 
inhibition of mitochondrial respiration at the level of complex III causes SOD1-dependent 
ROS production and apoptotic death of isolated blood lymphocytes. In contrast, 
mitochondria isolated from SOD1 knockout mice do not show increased ROS production 
upon mitochondrial stress. Moreover, accumulation of mutant human G93A-SOD1 in the 
IMS that is observed in the tg animal models of ALS, leads to elevated SOD1 activity and 
increased cytochrome c-catalyzed oxidation in the IMS.  
Our proposed model provides also an explanation for observations in other 
neurodegenerative disorders that elevated SOD1 activity worsens the pathology instead of 
the expected protective effect. For instance, immature mouse brains overexpressing SOD1 
show an increased propensity for injury and accumulate more hydroperoxide after hypoxia-
ischemia than wt mouse brains (Fullerton et al., 1998). Also, elevation of SOD1 increases 
acoustic trauma from noise exposure in some models (Endo et al., 2005). Impotantly, mice 
www.intechopen.com
  
Amyotrophic Lateral Sclerosis 
 
256 
deficient in SOD1 have been reported to be resistant to acetaminophen toxicity (Lei et al., 
2006). Even though SOD1 as a cytosolic antioxidant protects against mitochondrial 
dysfunction in a mouse model of transient focal cerebral ischemia (Fujimura et al., 2000), 
SOD1 deficiency, rather than overexpression, is associated with enhanced recovery and 
attenuated activation of NF-kappaB after brain trauma in mice (Beni et al., 2006).  
This apparent discrepancy concerning the role of SOD1 in cellular injury can be explained 
by the model introduced, showing that increased SOD1 activity in the IMS paradoxically 
produces peroxides which are converted to highly toxic ROS. This view is further supported 
by an observation in mouse model of genetic disorder ataxia-telangiectasia, where elevated 
levels of SOD1 exacerbate the phenotype of neurodegeneration (Peter et al., 2001). It is also 
of interest that SOD1 overexpression and high tissue dismutase activity may potentiate 
atherogenesis in fat-fed atherosclerosis-susceptible mice (Tribble et al., 1997). The evidence 
about deleterious role of increased SOD1 expression has been most recently complemented 
by studies demonstrating that overexpression of SOD1 in retina leads to increased 
hydroperoxide levels and accelerated damage of cone cells (Usui et al., n.d.). 
The key component for the SOD1-derived hydroperoxide toxicity in IMS is cytochrome c. 
Previous studies, including electron paramagnetic resonance (EPR) studies (Barr et al., 1996; 
Svistunenko, 2005; Belikova et al., 2006; Basova et al., 2007) have demonstrated that the 
reaction of cytochrome c with hydroperoxide results in formation of oxoferryl cytochrome c 
(peroxidase compound I-type intermediate) and corresponding protein-derived tyrosyl 
radical, which is highly reactive and has a potential to oxidize proteins, DNA, and lipids, as 
well as endogenous antioxidants such as glutathione, NADH, and ascorbate (Lawrence et 
al., 2003) (Fig. 3). In particular, oxidation of cardiolipin, a phospholipid which is in complex 
with cytochrome c on the surface of the inner mitochondrial membrane, causes the release of 
proapoptotic factors from mitochondria (Kagan et al., 2005; Belikova et al., 2006). This leads 
to a scenario where the hydroperoxide produced by increased SOD1 activity in the IMS, 
would thus serve as a substrate for cardiolipin-bound cytochrome c and consequently 
switch on very early proapoptotic processes, inducing consecutive programmed cell death. 
Additionally, upon increased hydroperoxide levels cytochrome c peroxidase activity may 
cause NADH oxidation producing a radical, which in turn donates an electron to oxygen 
augmenting superoxide formation (Velayutham et al., 2011). 
The toxicity based on the dismutase activity of mutant SOD1 in the IMS might also be true 
even for dismutase inactive mutant SOD1 proteins. In human FALS SOD1 mutations are 
dominantly inherited resulting in the presence of both wild type and mutant SOD1 subunits 
in each cell. Thus, dismutase activity lacking G85R-SOD1 can form active heterodimers with 
wt SOD1 molecules. In mice the co-expression of human mutant and wt SOD1 accelerated 
disease (Jaarsma et al., 2000; Fukada et al., 2001; Deng et al., 2006). Importantly, unaffected 
A4V-SOD1 mutant mice developed the disease only when mated with human wt SOD1 
overexpressing mice (Deng et al., 2006). It was also shown recently that the toxicity of 
mutant SOD1 dimers is not correlated with their capacity to form protein aggregates but 
rather with their dismutase activity (Witan et al., 2008). 
5. Conclusion 
Until now, several pathological mechanisms have been demonstrated how mutant SOD1 
induces mitochondrial dysfunction in FALS models. Among them, the emerging evidence 
indicates that the SOD1-dependant hydroperoxide production in mitochondrial IMS may 
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fuel the cytochrome c-catalyzed peroxidation and play a key role in oxidation of biological 
targets in the IMS. Thus, SOD1 activity and factors leading to its increase in this 
compartment can be regarded as deleterious mechanisms to the mitochondria and the cell. 
Increased SOD1 activity causing elevated hydroperoxide production in the IMS may be one 
of general mechanism in neurodegeneration.  
At the moment it is not clear how mutations in SOD1 directly affect hydroperoxide 
production in IMS. One possibility may be the already demonstrated increased 
mitochondrial import for mutant molecules in neurons of ALS models. Another possible 
mechanism is linked to less strict dismutase activity control. Altogether, we hypothesize that 
the mutant SOD1 may gain toxic features because the proper control mechanism for its 
dismutase activity in mitochondrial IMS may be lost. In conclusion, we suggest that SOD1 
activity in the IMS is a relevant therapeutic target for ALS and other neurodegenerative 
diseases involving mitochondrial pathogenesis.  
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